Overweight and obesity (BMI > 25) were associated with significantly reduced disease-specific survival rates in hormone receptor-negative patients as compared to non-obese patients (Fig. 1b). Here, NR4A1 is linked to obesity due to melanocortin 4 receptor deficiency.